Tissue repair and orthopedic recovery
Acute and chronic ligament sprains, tendonitis, muscle tears, post-surgical recovery, and joint degradation.
For laboratory research use only. Material is supplied as a research reference standard and is not approved by Health Canada. This protocol is reference information compiled from published literature and supplier documentation, not medical advice. Anyone with a health condition or on medication should speak to a physician first.
Phases
- 01
Phase 1: loading (weeks 1-4)
- BPC-157: 250 mcg subcutaneous twice daily (500 mcg total per day)
- TB-500: 2.5 mg subcutaneous twice weekly (5.0 mg total per week)
- 02
Phase 2: consolidation (weeks 5-8)
- BPC-157: 250 mcg subcutaneous once daily
- TB-500: 2.0 mg subcutaneous once weekly
- 03
Phase 3: maintenance / off-cycle
- Discontinue for 4 weeks before evaluating the need for a repeat cycle.
Operational notes
- Inject BPC-157 as close to the tissue site as comfortably possible.
- TB-500 can be injected into subcutaneous abdominal fat regardless of site.
Reconstitution
Concentrations depend on the vial size you received, so work them out per compound rather than from a generic chart. Each product's protocol page carries a table computed for the size we ship.
- 1Wipe rubber stoppers with 70% isopropyl alcohol prep pads before puncture.
- 2Direct bacteriostatic water down the inside glass wall of the vial. Never squirt it directly onto the lyophilized powder.
- 3Swirl or roll the vial gently between the palms until dissolved. Do not shake vigorously.
- 4Store reconstituted material refrigerated at 2 C to 8 C, protected from direct light.